Riluzole News
Riluzole currently has 0 news articles, with 20 predicted indications.
This page combines the AI-predicted indications for Riluzole with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Original indication: Rilutek is indicated to extend life or the time to mechanical ventilation for patients with amyotrophic lateral sclerosis (ALS). Clinical trials have demonstrated that Rilutek extends survival for...
- Evidence level: L5
- Predicted indications (20):
- bilateral parasagittal parieto-occipital polymicrogyria (100.0%)
- amyotrophic lateral sclerosis (100.0%)
- axial spondylometaphyseal dysplasia (100.0%)
- lower motor neuron syndrome with late-adult onset (100.0%)
- trichomegaly-retina pigmentary degeneration-dwarfism syndrome (100.0%)
- lethal arthrogryposis-anterior horn cell disease syndrome (100.0%)
- monomelic amyotrophy (100.0%)
- Mills syndrome (100.0%)
- amyotrophic lateral sclerosis, susceptibility to (100.0%)
- autosomal dominant mitochondrial myopathy with exercise intolerance (100.0%)
- amyotrohpic lateral sclerosis type 22 (100.0%)
- polymicrogyria, perisylvian, with cerebellar hypoplasia and arthrogryposis (99.7%)
- hydranencephaly (disease) (99.7%)
- congenital disorder of glycosylation with defective fucosylation (99.7%)
- schizophrenia (99.7%)
- retinal dystrophy with or without extraocular anomalies (99.6%)
- atypical glycine encephalopathy (99.6%)
- Charcot-Marie-Tooth disease, demyelinating, type 1G (99.6%)
- myopia 26, X-linked, female-limited (99.5%)
- syndromic myopia (99.5%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.